Anne Peters, MD
Director, USC Clinical Diabetes Program
Professor of Clinical Medicine, Keck School of Medicine of USC
University of Southern California
Los Angeles, CA
Jay H. Shubrook, DO, FACOFP, FAAFP
Professor, Primary Care Department
Director of Clinical Research and Diabetes Services
Touro University California
College of Osteopathic Medicine
Jaime Symowicz, PhD
Manager, Educational Strategy and Content
Aaron J. Kowalski, PhD
President and CEO
New York, NY
Nicole Johnson, DrPH, MPH, MA
New York, NY
Aly Bancroft, MPH
Associate Program Officer
Type 1 Diabetes Program
The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
East Lansing, MI
Upon completion, participants should be able to:
- Describe the benefits and limitations of using HbA1c to measure outcomes for patients with T1D
- Summarize the clinical implications of glucose variability, time in range, and glucose management indicator
This activity is intended for primary care clinicians (primary care physicians, pediatricians, nurse practitioners, physician assistants, and nurses), pharmacists, endocrinologists, and certified diabetes educators.
Statement of Need
In the United States, approximately 1.25 million individuals have type 1 diabetes (T1D), which includes about 200,000 youth (those younger than 20 years old) and more than 1 million adults (those age 20 and older). Among these individuals, only 17% of youth and 21% of adults are reaching their HbA1c goals. In addition, T1D is a challenging and demanding condition, and many individuals are burdened by insulin treatment plans, hypoglycemia concerns, and psychosocial issues. However, technological advances and new therapies continue to emerge that can help address patients’ challenges and encourage them take a more active role in their care. Because the incidence of T1D is expected to increase to 5 million people by 2050, it is imperative that primary care clinicians stay up-to-date on all aspects of T1D care to improve patient outcomes, such as other measures to assess clinical outcomes; the role of continuous glucose monitoring, insulin pumps, and adjunctive therapies; and the importance of providing support for psychosocial issues.
This activity was developed by Med-IQ in collaboration with JDRF and The Leona M. and Harry B. Helmsley Charitable Trust.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Med-IQ is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This nursing activity has been approved for up to 0.5 contact hour.
Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hour (0.05 CEU) of credit for pharmacists. ACPE #0476-0000-19-001-H01-P. This knowledge-based activity is designed for all pharmacists.
Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Instructions to Receive Credit
To receive credit, read the introductory CE material, watch the webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: July 30, 2019
Expiration Date: July 29, 2020
Estimated Time to Complete This Activity: 30 minutes
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Anne Peters, MD
Consulting fees/advisory boards: Abbott Laboratories, Becton, Dickinson and Company, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Lexicon Pharmaceuticals, Inc., Livongo, MannKind Corporation, Merck & Co., Inc., Novo Nordisk, Omada Health, Inc., Optum, Inc., Sanofi-aventis U.S. Inc., Zafgen, Inc.
Fees received for promotional/non-CME activities: Novo Nordisk
Contracted research: AstraZeneca, Dexcom, Inc., MannKind Corporation
Jay H. Shubrook, DO, FACOFP, FAAFP
Consulting fees/advisory boards: Eli Lilly and Company, Novo Nordisk, Intarcia Therapeutics, Inc.
The peer reviewers and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email email@example.com.
Operating system - Med-IQ supports the following operating systems:
- Microsoft Windows supported by Microsoft
- Mac OS supported by Apple
Browsers - Med-IQ supports the current version of each browser listed below, plus two prior versions:
Microsoft Internet Explorer
- Microsoft Edge
Operating system - Med-IQ supports the current operating system, plus two prior releases:
- Android (eg, Samsung Galaxy)
- Apple (eg, iPhone/iPad)
Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
- Android (Chrome)
- Apple (Safari)
Applications & Software
PDF Viewer - Adobe Acrobat Reader or Adobe Reader
Adobe Flash Player - Med-IQ supports the current version, plus two prior versions
For technical assistance, please refer to our Support Manual.
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Acknowledgment of Commercial Support
This activity is funded in part by JDRF and The Leona M. and Harry B. Helmsley Charitable Trust and supported by an educational grant from Novo Nordisk, Inc.
© 2019 JDRF, Inc.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.